| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription factor binding | SETD1A FLNA TCF4 CRTC3 GATA6 SALL4 PRPF6 CAMTA2 ARID1A CREBBP MEF2C MEF2D DDIT3 BBS10 TGFB1I1 JUN NFIA CD34 BSN | 1.25e-08 | 753 | 105 | 19 | GO:0008134 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | SETD1A FLNA TCF4 CRTC3 GATA6 PRPF6 ARID1A CREBBP MEF2C MEF2D DDIT3 BBS10 TGFB1I1 JUN NFIA CD34 | 6.28e-08 | 582 | 105 | 16 | GO:0140297 |
| GeneOntologyMolecularFunction | transcription coactivator activity | MAML1 PRPF6 CAMTA2 NIBAN2 ZMIZ1 ARID1A CREBBP TGFB1I1 RBM14 TRIM8 SMARCD1 | 5.76e-07 | 303 | 105 | 11 | GO:0003713 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | SETD1A GATA6 PRPF6 ARID1A CREBBP MEF2C MEF2D DDIT3 BBS10 TGFB1I1 JUN CD34 | 1.99e-06 | 417 | 105 | 12 | GO:0061629 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | SHANK1 TCF4 MAML1 PRPF6 CAMTA2 NIBAN2 ZMIZ1 CPT1A ARID1A WNK1 CREBBP DDIT3 LGALS3 TGFB1I1 RBM14 TRIM8 DYNC1LI1 SMARCD1 PRNP SPSB2 | 2.27e-06 | 1160 | 105 | 20 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | SHANK1 TCF4 MAML1 PRPF6 CAMTA2 NIBAN2 ZMIZ1 CPT1A ARID1A WNK1 CREBBP DDIT3 LGALS3 TAB3 TGFB1I1 RBM14 TRIM8 DYNC1LI1 SMARCD1 PRNP SPSB2 | 6.56e-06 | 1356 | 105 | 21 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coregulator activity | TCF4 MAML1 PRPF6 CAMTA2 NIBAN2 ZMIZ1 ARID1A CREBBP DDIT3 TGFB1I1 RBM14 TRIM8 SMARCD1 | 7.93e-06 | 562 | 105 | 13 | GO:0003712 |
| GeneOntologyMolecularFunction | cAMP response element binding protein binding | 3.00e-05 | 12 | 105 | 3 | GO:0008140 | |
| GeneOntologyMolecularFunction | SMAD binding | 9.07e-05 | 86 | 105 | 5 | GO:0046332 | |
| GeneOntologyMolecularFunction | HMG box domain binding | 2.32e-04 | 23 | 105 | 3 | GO:0071837 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | FOXE1 TCF4 ZFP90 ZBTB38 GATA6 SALL4 MEF2C MEF2D DDIT3 HOXA3 JUN FOXB1 HOXB7 OTX1 NFIA PAX1 ZBTB3 EN1 | 3.85e-04 | 1412 | 105 | 18 | GO:0000981 |
| GeneOntologyMolecularFunction | TFIIB-class transcription factor binding | 4.05e-04 | 6 | 105 | 2 | GO:0001093 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.78e-04 | 188 | 105 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | Fc-gamma receptor I complex binding | 5.65e-04 | 7 | 105 | 2 | GO:0034988 | |
| GeneOntologyMolecularFunction | splicing factor binding | 5.65e-04 | 7 | 105 | 2 | GO:1990935 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FOXE1 TCF4 ZFP90 ZBTB38 GATA6 SALL4 CREBBP MEF2C MEF2D DDIT3 HOXA3 JUN FOXB1 HOXB7 OTX1 NFIA PAX1 EN1 | 5.68e-04 | 1459 | 105 | 18 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | FOXE1 TCF4 ZBTB38 GATA6 SALL4 MEF2C MEF2D DDIT3 HOXA3 JUN FOXB1 HOXB7 OTX1 NFIA PAX1 EN1 | 7.65e-04 | 1244 | 105 | 16 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | FOXE1 TCF4 ZBTB38 GATA6 SALL4 MEF2C MEF2D DDIT3 HOXA3 JUN FOXB1 HOXB7 OTX1 NFIA PAX1 EN1 | 9.61e-04 | 1271 | 105 | 16 | GO:0000987 |
| GeneOntologyMolecularFunction | UDP phosphatase activity | 9.63e-04 | 9 | 105 | 2 | GO:0045134 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.40e-03 | 42 | 105 | 3 | GO:0098918 | |
| GeneOntologyMolecularFunction | molecular condensate scaffold activity | 1.40e-03 | 42 | 105 | 3 | GO:0140693 | |
| GeneOntologyMolecularFunction | minor groove of adenine-thymine-rich DNA binding | 1.46e-03 | 11 | 105 | 2 | GO:0003680 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 1.46e-03 | 11 | 105 | 2 | GO:0098919 | |
| GeneOntologyMolecularFunction | GDP phosphatase activity | 1.75e-03 | 12 | 105 | 2 | GO:0004382 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 2.06e-03 | 13 | 105 | 2 | GO:0098879 | |
| GeneOntologyMolecularFunction | protein domain specific binding | SHANK1 CREBBP MEF2C DDIT3 HOXA3 JUN AFAP1L2 NPTXR SYP TNK2 AFDN SRRM2 | 2.15e-03 | 875 | 105 | 12 | GO:0019904 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 2.78e-03 | 560 | 105 | 9 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 2.99e-03 | 566 | 105 | 9 | GO:0001216 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | FOXE1 EPOR FLNA DDR1 FRAS1 GATA6 LAMB1 ZMIZ1 ARID1A MEF2C RBM20 MEF2D BBS10 HOXA3 SLC6A4 JUN HOXB7 OTX1 PBRM1 PNPLA6 MEGF8 CD34 AFDN PAX1 ELN CSMD1 | 6.87e-10 | 1269 | 105 | 26 | GO:0009887 |
| GeneOntologyBiologicalProcess | embryo development | FOXE1 EPOR FRAS1 SHROOM3 COL12A1 GATA6 SALL4 NIBAN2 ZMIZ1 CUBN ARID1A WNK1 CREBBP MEF2C OTUD7B HOXA3 TGFB1I1 FOXB1 HOXB7 OTX1 PBRM1 MEGF8 RBM14 PRICKLE2 PAX1 EN1 | 9.31e-09 | 1437 | 105 | 26 | GO:0009790 |
| GeneOntologyBiologicalProcess | tube development | EPOR FLNA DDR1 TCF4 SHROOM3 MIA3 GATA6 SALL4 NIBAN2 ZMIZ1 ARID1A WNK1 MEF2C LGALS3 RASIP1 JUN FOXB1 HOXB7 PBRM1 PNPLA6 MEGF8 NFIA CD34 CSMD1 EN1 | 2.56e-08 | 1402 | 105 | 25 | GO:0035295 |
| GeneOntologyBiologicalProcess | tube morphogenesis | EPOR FLNA DDR1 TCF4 SHROOM3 MIA3 GATA6 SALL4 NIBAN2 ZMIZ1 ARID1A WNK1 MEF2C LGALS3 RASIP1 JUN HOXB7 PBRM1 PNPLA6 MEGF8 CD34 CSMD1 | 4.18e-08 | 1125 | 105 | 22 | GO:0035239 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | FOXE1 FRAS1 SHROOM3 COL12A1 GATA6 SALL4 ARID1A WNK1 CREBBP MEF2C HOXA3 TGFB1I1 HOXB7 OTX1 MEGF8 RBM14 EN1 | 1.14e-07 | 713 | 105 | 17 | GO:0048598 |
| GeneOntologyBiologicalProcess | learning or memory | SHANK1 LAMB1 CREBBP MEF2C SLC6A4 RIN1 JUN FOXB1 CTNND2 CSMD1 EN1 PRNP | 4.42e-07 | 373 | 105 | 12 | GO:0007611 |
| GeneOntologyBiologicalProcess | blood vessel development | EPOR FLNA TCF4 MIA3 GATA6 NIBAN2 ZMIZ1 ARID1A WNK1 MEF2C DDIT3 LGALS3 RASIP1 JUN PBRM1 PNPLA6 MEGF8 CD34 | 9.77e-07 | 929 | 105 | 18 | GO:0001568 |
| GeneOntologyBiologicalProcess | epithelium development | FOXE1 EPOR FLNA DDR1 FRAS1 SHROOM3 GATA6 SALL4 FLG2 ARID1A MEF2C TGFB1I1 RASIP1 JUN FOXB1 HOXB7 PBRM1 MEGF8 PKP3 AFDN PAX1 CSMD1 EN1 | 1.04e-06 | 1469 | 105 | 23 | GO:0060429 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | FLNA TCF4 SHROOM3 MIA3 COL12A1 TNFSF13 GATA6 SALL4 NIBAN2 ARID1A WNK1 MEF2C RBM20 LGALS3 HOXA3 MFSD14A RASIP1 JUN FOXB1 PBRM1 PNPLA6 CD34 PAX1 | 1.22e-06 | 1483 | 105 | 23 | GO:0048646 |
| GeneOntologyBiologicalProcess | cognition | SHANK1 LAMB1 CREBBP MEF2C SLC6A4 RIN1 JUN FOXB1 CTNND2 CSMD1 EN1 PRNP | 1.66e-06 | 423 | 105 | 12 | GO:0050890 |
| GeneOntologyBiologicalProcess | vasculature development | EPOR FLNA TCF4 MIA3 GATA6 NIBAN2 ZMIZ1 ARID1A WNK1 MEF2C DDIT3 LGALS3 RASIP1 JUN PBRM1 PNPLA6 MEGF8 CD34 | 1.78e-06 | 969 | 105 | 18 | GO:0001944 |
| GeneOntologyBiologicalProcess | circulatory system development | EPOR FLNA TCF4 MIA3 MAML1 GATA6 SALL4 NIBAN2 ZMIZ1 ARID1A WNK1 MEF2C RBM20 DDIT3 LGALS3 RASIP1 JUN PBRM1 PNPLA6 MEGF8 CD34 ELN | 2.85e-06 | 1442 | 105 | 22 | GO:0072359 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | FOXE1 FLNA DDR1 FRAS1 SHROOM3 SALL4 FLG2 ARID1A MEF2C TGFB1I1 RASIP1 HOXB7 MEGF8 CSMD1 | 3.08e-06 | 619 | 105 | 14 | GO:0002009 |
| GeneOntologyBiologicalProcess | neuron development | SHANK1 EPOR FLNA DDR1 LAMB1 NIBAN2 ADGRV1 ZMIZ1 WNK1 CREBBP MEF2C JUN FOXB1 PBRM1 MEGF8 NPTXR P3H1 PRICKLE2 AFDN GRIP2 CTNND2 EN1 | 3.61e-06 | 1463 | 105 | 22 | GO:0048666 |
| GeneOntologyBiologicalProcess | heart morphogenesis | 5.66e-06 | 321 | 105 | 10 | GO:0003007 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | FOXE1 EPOR FLNA DDR1 FRAS1 SHROOM3 SALL4 FLG2 ARID1A MEF2C TGFB1I1 RASIP1 HOXB7 MEGF8 CSMD1 | 5.94e-06 | 750 | 105 | 15 | GO:0048729 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | FLNA MIA3 LAMB1 ADGRV1 ZMIZ1 ARID1A WNK1 LGALS3 SLC6A4 PBRM1 PKP3 CD34 LPP SMARCD1 AFDN CTNND2 PCDH7 PRNP | 7.75e-06 | 1077 | 105 | 18 | GO:0098609 |
| GeneOntologyBiologicalProcess | learning | 1.30e-05 | 212 | 105 | 8 | GO:0007612 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | EPOR FLNA TCF4 MIA3 GATA6 NIBAN2 ZMIZ1 WNK1 LGALS3 RASIP1 JUN PBRM1 PNPLA6 MEGF8 CD34 | 1.64e-05 | 817 | 105 | 15 | GO:0048514 |
| GeneOntologyBiologicalProcess | limb development | 1.93e-05 | 224 | 105 | 8 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 1.93e-05 | 224 | 105 | 8 | GO:0048736 | |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 2.01e-05 | 65 | 105 | 5 | GO:0045815 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TCF4 CRTC3 ZBTB38 MAML1 GATA6 SALL4 PRPF6 CAMTA2 ZMIZ1 CREBBP MEF2C MEF2D DDIT3 JUN HOXB7 OTX1 NFIA RBM14 PAX1 EN1 | 2.06e-05 | 1390 | 105 | 20 | GO:0045944 |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 2.51e-05 | 68 | 105 | 5 | GO:0141137 | |
| GeneOntologyBiologicalProcess | heart development | EPOR FLNA MAML1 GATA6 SALL4 ZMIZ1 ARID1A WNK1 MEF2C RBM20 JUN PBRM1 MEGF8 ELN | 2.97e-05 | 757 | 105 | 14 | GO:0007507 |
| GeneOntologyBiologicalProcess | chordate embryonic development | SHROOM3 GATA6 SALL4 ZMIZ1 CUBN ARID1A MEF2C OTUD7B HOXA3 FOXB1 HOXB7 PBRM1 MEGF8 PAX1 EN1 | 5.39e-05 | 906 | 105 | 15 | GO:0043009 |
| GeneOntologyBiologicalProcess | myoblast differentiation | 6.93e-05 | 136 | 105 | 6 | GO:0045445 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | SHROOM3 GATA6 SALL4 ZMIZ1 CUBN ARID1A MEF2C OTUD7B HOXA3 FOXB1 HOXB7 PBRM1 MEGF8 PAX1 EN1 | 7.15e-05 | 929 | 105 | 15 | GO:0009792 |
| GeneOntologyBiologicalProcess | positive regulation of serotonin secretion | 7.68e-05 | 3 | 105 | 2 | GO:0014064 | |
| GeneOntologyBiologicalProcess | neuron projection development | SHANK1 EPOR FLNA DDR1 LAMB1 NIBAN2 ADGRV1 CREBBP MEF2C JUN FOXB1 PBRM1 MEGF8 NPTXR P3H1 PRICKLE2 AFDN CTNND2 | 8.03e-05 | 1285 | 105 | 18 | GO:0031175 |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 8.24e-05 | 87 | 105 | 5 | GO:0001974 | |
| GeneOntologyBiologicalProcess | dendritic spine development | 8.47e-05 | 141 | 105 | 6 | GO:0060996 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine development | 1.02e-04 | 91 | 105 | 5 | GO:0060998 | |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 1.07e-04 | 92 | 105 | 5 | GO:0045661 | |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 1.11e-04 | 148 | 105 | 6 | GO:1902414 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 1.65e-04 | 54 | 105 | 4 | GO:0045663 | |
| GeneOntologyBiologicalProcess | cellular component maintenance | 1.67e-04 | 101 | 105 | 5 | GO:0043954 | |
| GeneOntologyBiologicalProcess | behavior | SHANK1 LAMB1 CPT1A CREBBP MEF2C SLC6A4 RIN1 USP2 JUN FOXB1 CTNND2 CSMD1 EN1 PRNP | 1.69e-04 | 891 | 105 | 14 | GO:0007610 |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | TCF4 MAML1 LAMB1 NIBAN2 ZMIZ1 ARID1A MEF2C LGALS3 TGFB1I1 JUN PBRM1 MEGF8 CD34 SMARCD1 AFDN GRIP2 | 2.07e-04 | 1141 | 105 | 16 | GO:0045597 |
| GeneOntologyBiologicalProcess | positive regulation of skeletal muscle tissue development | 2.72e-04 | 25 | 105 | 3 | GO:0048643 | |
| GeneOntologyBiologicalProcess | anterior/posterior pattern specification | 2.73e-04 | 247 | 105 | 7 | GO:0009952 | |
| GeneOntologyBiologicalProcess | skeletal system development | MIA3 MEF2C MEF2D LGALS3 HOXA3 HOXB7 MEGF8 NFIA P3H1 PAX1 EN1 | 2.99e-04 | 615 | 105 | 11 | GO:0001501 |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 3.01e-04 | 421 | 105 | 9 | GO:0060562 | |
| GeneOntologyBiologicalProcess | cell junction maintenance | 3.38e-04 | 65 | 105 | 4 | GO:0034331 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 3.45e-04 | 118 | 105 | 5 | GO:0001570 | |
| GeneOntologyBiologicalProcess | memory | 3.50e-04 | 183 | 105 | 6 | GO:0007613 | |
| GeneOntologyBiologicalProcess | pattern specification process | 3.53e-04 | 526 | 105 | 10 | GO:0007389 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 3.70e-04 | 185 | 105 | 6 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 3.70e-04 | 185 | 105 | 6 | GO:0035108 | |
| GeneOntologyBiologicalProcess | conditioned place preference | 3.80e-04 | 6 | 105 | 2 | GO:1990708 | |
| GeneOntologyBiologicalProcess | muscle structure development | EPOR MAML1 GATA6 LAMB1 NIBAN2 ARID1A MEF2C MEF2D DDIT3 USP2 PBRM1 SMARCD1 ELN | 4.15e-04 | 858 | 105 | 13 | GO:0061061 |
| GeneOntologyBiologicalProcess | embryonic brain development | 4.25e-04 | 29 | 105 | 3 | GO:1990403 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 4.25e-04 | 29 | 105 | 3 | GO:2000819 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle tissue development | 4.25e-04 | 29 | 105 | 3 | GO:1901863 | |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine development | 4.49e-04 | 70 | 105 | 4 | GO:0060999 | |
| GeneOntologyBiologicalProcess | regulation of neuron apoptotic process | 4.66e-04 | 355 | 105 | 8 | GO:0043523 | |
| GeneOntologyBiologicalProcess | associative learning | 5.37e-04 | 130 | 105 | 5 | GO:0008306 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | SHANK1 WNK1 MEF2C SLC6A4 RIN1 SYP AFDN GRIP2 CTNND2 BSN PRNP | 5.62e-04 | 663 | 105 | 11 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | SHANK1 WNK1 MEF2C SLC6A4 RIN1 SYP AFDN GRIP2 CTNND2 BSN PRNP | 5.69e-04 | 664 | 105 | 11 | GO:0099177 |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle tissue development | 6.26e-04 | 33 | 105 | 3 | GO:0048641 | |
| GeneOntologyBiologicalProcess | animal organ formation | 6.77e-04 | 78 | 105 | 4 | GO:0048645 | |
| GeneOntologyBiologicalProcess | parathyroid gland development | 7.05e-04 | 8 | 105 | 2 | GO:0060017 | |
| GeneOntologyBiologicalProcess | synapse organization | SHANK1 FLNA MEF2C NFIA NPTXR PRICKLE2 AFDN GRIP2 CTNND2 BSN PRNP | 7.35e-04 | 685 | 105 | 11 | GO:0050808 |
| GeneOntologyBiologicalProcess | regionalization | 7.52e-04 | 478 | 105 | 9 | GO:0003002 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 7.59e-04 | 212 | 105 | 6 | GO:0003205 | |
| GeneOntologyBiologicalProcess | gastrulation | 7.59e-04 | 212 | 105 | 6 | GO:0007369 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 8.56e-04 | 83 | 105 | 4 | GO:0060976 | |
| GeneOntologyBiologicalProcess | atrioventricular node development | 9.03e-04 | 9 | 105 | 2 | GO:0003162 | |
| GeneOntologyBiologicalProcess | maintenance of postsynaptic density structure | 9.03e-04 | 9 | 105 | 2 | GO:0099562 | |
| GeneOntologyBiologicalProcess | regulation of ossification | 9.36e-04 | 147 | 105 | 5 | GO:0030278 | |
| GeneOntologyBiologicalProcess | angiogenesis | FLNA TCF4 MIA3 GATA6 NIBAN2 WNK1 LGALS3 RASIP1 JUN PNPLA6 CD34 | 9.62e-04 | 708 | 105 | 11 | GO:0001525 |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 9.65e-04 | 148 | 105 | 5 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 9.65e-04 | 148 | 105 | 5 | GO:0035113 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 1.07e-03 | 88 | 105 | 4 | GO:0071277 | |
| GeneOntologyBiologicalProcess | maintenance of synapse structure | 1.10e-03 | 40 | 105 | 3 | GO:0099558 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 1.11e-03 | 313 | 105 | 7 | GO:0099173 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | NIBAN2 ZMIZ1 ARID1A LGALS3 JUN PBRM1 MEGF8 SMARCD1 AFDN GRIP2 | 1.16e-03 | 614 | 105 | 10 | GO:0010720 |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 1.18e-03 | 231 | 105 | 6 | GO:0006352 | |
| GeneOntologyBiologicalProcess | neuron apoptotic process | 1.24e-03 | 413 | 105 | 8 | GO:0051402 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 1.27e-03 | 42 | 105 | 3 | GO:0070316 | |
| GeneOntologyBiologicalProcess | muscle hypertrophy in response to stress | 1.27e-03 | 42 | 105 | 3 | GO:0003299 | |
| GeneOntologyBiologicalProcess | cardiac muscle hypertrophy in response to stress | 1.27e-03 | 42 | 105 | 3 | GO:0014898 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron apoptotic process | 1.32e-03 | 236 | 105 | 6 | GO:0043524 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 1.35e-03 | 237 | 105 | 6 | GO:0019827 | |
| GeneOntologyBiologicalProcess | cell activation | FLNA TCF4 CRTC3 TNFSF13 ZMIZ1 ARID1A MEF2C LGALS3 SLC6A4 ZP1 JUN PBRM1 ENTPD2 SMARCD1 PAX1 PRNP | 1.35e-03 | 1356 | 105 | 16 | GO:0001775 |
| GeneOntologyBiologicalProcess | protein localization to plasma membrane | 1.35e-03 | 324 | 105 | 7 | GO:0072659 | |
| GeneOntologyBiologicalProcess | outflow tract morphogenesis | 1.36e-03 | 94 | 105 | 4 | GO:0003151 | |
| GeneOntologyBiologicalProcess | positive regulation of excitatory postsynaptic potential | 1.36e-03 | 43 | 105 | 3 | GO:2000463 | |
| GeneOntologyBiologicalProcess | cardiac muscle adaptation | 1.36e-03 | 43 | 105 | 3 | GO:0014887 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase I | 1.37e-03 | 11 | 105 | 2 | GO:0016479 | |
| GeneOntologyBiologicalProcess | regulation of germinal center formation | 1.37e-03 | 11 | 105 | 2 | GO:0002634 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 1.42e-03 | 95 | 105 | 4 | GO:0030071 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 1.42e-03 | 95 | 105 | 4 | GO:2000781 | |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | 1.42e-03 | 422 | 105 | 8 | GO:1990778 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 1.46e-03 | 44 | 105 | 3 | GO:0045023 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 1.50e-03 | 242 | 105 | 6 | GO:1902107 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 1.50e-03 | 242 | 105 | 6 | GO:0098727 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 1.50e-03 | 242 | 105 | 6 | GO:1903708 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 1.59e-03 | 98 | 105 | 4 | GO:1902099 | |
| GeneOntologyBiologicalProcess | regulation of serotonin secretion | 1.64e-03 | 12 | 105 | 2 | GO:0014062 | |
| GeneOntologyCellularComponent | chromatin | FOXE1 SETD1A TCF4 GATA6 SALL4 CAMTA2 ZMIZ1 ARID1A CREBBP MEF2C MEF2D DDIT3 HOXA3 JUN FOXB1 HOXB7 OTX1 PBRM1 NFIA SMARCD1 PAX1 EN1 | 2.97e-06 | 1480 | 104 | 22 | GO:0000785 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | FRAS1 COL12A1 LAMB1 COL6A5 LGALS3 TGFB1I1 ZP1 P3H1 ENTPD2 ELN | 3.12e-04 | 530 | 104 | 10 | GO:0062023 |
| GeneOntologyCellularComponent | SWI/SNF complex | 4.40e-04 | 30 | 104 | 3 | GO:0016514 | |
| MousePheno | ventricular hypoplasia | 4.46e-06 | 99 | 94 | 7 | MP:0000279 | |
| MousePheno | dilated dorsal aorta | 5.46e-06 | 18 | 94 | 4 | MP:0004068 | |
| MousePheno | abnormal heart septum morphology | EPOR FLNA FRAS1 SHROOM3 SALL4 ARID1A CREBBP OTUD7B HOXA3 JUN PBRM1 MEGF8 | 1.08e-05 | 388 | 94 | 12 | MP:0006113 |
| MousePheno | abnormal interventricular septum morphology | EPOR FLNA FRAS1 SHROOM3 SALL4 ARID1A CREBBP OTUD7B JUN PBRM1 MEGF8 | 1.80e-05 | 342 | 94 | 11 | MP:0000281 |
| MousePheno | abnormal heart ventricle morphology | EPOR FLNA FRAS1 SHROOM3 SALL4 ARID1A WNK1 CREBBP MEF2C RBM20 OTUD7B HOXA3 SLC6A4 JUN PBRM1 MEGF8 ELN | 1.88e-05 | 793 | 94 | 17 | MP:0005294 |
| MousePheno | decreased inferior colliculus size | 2.40e-05 | 9 | 94 | 3 | MP:0009038 | |
| MousePheno | abnormal artery morphology | FLNA DDR1 ZMIZ1 WNK1 MEF2C HOXA3 SLC6A4 RASIP1 JUN PNPLA6 MEGF8 ELN | 3.75e-05 | 440 | 94 | 12 | MP:0002191 |
| MousePheno | ventricular septal defect | 6.41e-05 | 261 | 94 | 9 | MP:0010402 | |
| MousePheno | abnormal cardiovascular development | EPOR FLNA SHROOM3 SALL4 ZMIZ1 CUBN ARID1A WNK1 CREBBP MEF2C HOXA3 RASIP1 JUN PNPLA6 MEGF8 ELN | 8.07e-05 | 802 | 94 | 16 | MP:0002925 |
| MousePheno | ventricle myocardium hypoplasia | 1.13e-04 | 71 | 94 | 5 | MP:0010502 | |
| MousePheno | abnormal pectoral girdle bone morphology | 1.89e-04 | 301 | 94 | 9 | MP:0004508 | |
| MousePheno | abnormal dorsal aorta morphology | 2.11e-04 | 81 | 94 | 5 | MP:0004787 | |
| MousePheno | increased inferior colliculus size | 2.66e-04 | 4 | 94 | 2 | MP:0000777 | |
| MousePheno | abnormal artery development | 2.72e-04 | 133 | 94 | 6 | MP:0003410 | |
| MousePheno | myocardium hypoplasia | 2.80e-04 | 86 | 94 | 5 | MP:0010500 | |
| MousePheno | abnormal gastrulation | SETD1A GATA6 LAMB1 SALL4 CUBN ARID1A CLCC1 PNPLA6 MEGF8 RBM14 AFDN | 3.02e-04 | 469 | 94 | 11 | MP:0001695 |
| MousePheno | abnormal inferior colliculus morphology | 3.09e-04 | 20 | 94 | 3 | MP:0000776 | |
| MousePheno | abnormal sternum morphology | 3.16e-04 | 255 | 94 | 8 | MP:0000157 | |
| MousePheno | abnormal extraembryonic tissue morphology | EPOR LAMB1 SALL4 ZMIZ1 CUBN ARID1A WNK1 CREBBP MEF2C RASIP1 JUN PBRM1 PNPLA6 RBM14 TMEM209 AFDN | 3.35e-04 | 908 | 94 | 16 | MP:0002086 |
| MousePheno | abnormal sternebra morphology | 4.05e-04 | 52 | 94 | 4 | MP:0004322 | |
| MousePheno | increased superior colliculus size | 4.42e-04 | 5 | 94 | 2 | MP:0000905 | |
| Domain | CUB | 7.63e-06 | 49 | 104 | 5 | PF00431 | |
| Domain | CUB | 8.44e-06 | 50 | 104 | 5 | SM00042 | |
| Domain | - | 1.03e-05 | 52 | 104 | 5 | 2.60.120.290 | |
| Domain | CUB | 1.13e-05 | 53 | 104 | 5 | PS01180 | |
| Domain | CUB_dom | 1.62e-05 | 57 | 104 | 5 | IPR000859 | |
| Domain | HJURP_C | 1.83e-04 | 4 | 104 | 2 | IPR022102 | |
| Domain | HJURP_C | 1.83e-04 | 4 | 104 | 2 | PF12347 | |
| Domain | MADS_MEF2-like | 1.83e-04 | 4 | 104 | 2 | IPR033896 | |
| Domain | DIL | 4.54e-04 | 6 | 104 | 2 | PF01843 | |
| Domain | MADS | 4.54e-04 | 6 | 104 | 2 | SM00432 | |
| Domain | MADS_BOX_1 | 4.54e-04 | 6 | 104 | 2 | PS00350 | |
| Domain | Dilute_dom | 4.54e-04 | 6 | 104 | 2 | IPR002710 | |
| Domain | SRF-TF | 4.54e-04 | 6 | 104 | 2 | PF00319 | |
| Domain | MADS_BOX_2 | 4.54e-04 | 6 | 104 | 2 | PS50066 | |
| Domain | DILUTE | 4.54e-04 | 6 | 104 | 2 | PS51126 | |
| Domain | DIL | 4.54e-04 | 6 | 104 | 2 | SM01132 | |
| Domain | Plakophilin/d_Catenin | 6.33e-04 | 7 | 104 | 2 | IPR028435 | |
| Domain | TF_MADSbox | 6.33e-04 | 7 | 104 | 2 | IPR002100 | |
| Domain | RA | 6.73e-04 | 31 | 104 | 3 | SM00314 | |
| Domain | Calx_beta | 8.41e-04 | 8 | 104 | 2 | SM00237 | |
| Domain | GDA1_CD39_NTPase | 8.41e-04 | 8 | 104 | 2 | IPR000407 | |
| Domain | GDA1_CD39 | 8.41e-04 | 8 | 104 | 2 | PF01150 | |
| Domain | GDA1_CD39_NTPASE | 8.41e-04 | 8 | 104 | 2 | PS01238 | |
| Domain | RA | 1.05e-03 | 36 | 104 | 3 | PF00788 | |
| Domain | Calx_beta | 1.08e-03 | 9 | 104 | 2 | IPR003644 | |
| Domain | Calx-beta | 1.08e-03 | 9 | 104 | 2 | PF03160 | |
| Domain | RA | 1.14e-03 | 37 | 104 | 3 | PS50200 | |
| Domain | ConA-like_dom | 1.42e-03 | 219 | 104 | 6 | IPR013320 | |
| Domain | RA_dom | 1.43e-03 | 40 | 104 | 3 | IPR000159 | |
| Domain | EGF_3 | 1.95e-03 | 12 | 104 | 2 | PF12947 | |
| Domain | EGF_dom | 1.95e-03 | 12 | 104 | 2 | IPR024731 | |
| Domain | - | 1.96e-03 | 95 | 104 | 4 | 2.60.120.200 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 4.99e-05 | 70 | 81 | 5 | M938 | |
| Pathway | WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION | 1.10e-04 | 132 | 81 | 6 | M48110 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3 | 1.41e-04 | 87 | 81 | 5 | M39465 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 1.75e-04 | 91 | 81 | 5 | M39700 | |
| Pathway | REACTOME_HEME_SIGNALING | 1.76e-04 | 49 | 81 | 4 | M41832 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 2.60e-04 | 22 | 81 | 3 | MM1370 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 2.76e-04 | 55 | 81 | 4 | M27145 | |
| Pathway | WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS | 3.03e-04 | 159 | 81 | 6 | M39373 | |
| Pathway | WP_EGFEGFR_SIGNALING | 3.35e-04 | 162 | 81 | 6 | M39334 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.39e-04 | 24 | 81 | 3 | M13404 | |
| Pathway | REACTOME_MYOGENESIS | 3.39e-04 | 24 | 81 | 3 | MM15174 | |
| Pathway | PID_AR_PATHWAY | 4.12e-04 | 61 | 81 | 4 | M58 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_PERK_ATF4_SIGNALING_PATHWAY | 4.82e-04 | 6 | 81 | 2 | M47759 | |
| Pathway | REACTOME_MYOGENESIS | 6.00e-04 | 29 | 81 | 3 | M853 | |
| Pubmed | TCF4 ZFP90 GATA6 ARID1A CREBBP MEF2C MEF2D DDIT3 JUN HOXB7 OTX1 PBRM1 NFIA TRIM8 SMARCD1 AFDN PAX1 ZBTB3 | 5.42e-12 | 709 | 106 | 18 | 22988430 | |
| Pubmed | SETD1A TCF4 SEC24A LIN54 MAML1 GATA6 ZMIZ1 FLG2 ARID1A CREBBP MEF2C RBM20 MEF2D TAB3 MSI2 JUN PBRM1 NFIA SMARCD1 EN1 SRRM2 PCDH7 | 3.05e-10 | 1429 | 106 | 22 | 35140242 | |
| Pubmed | SHANK1 FLNA CRTC3 RANBP9 LAMB1 WNK1 CREBBP MEF2C MEF2D MSI2 JUN TLK1 TNK2 | 3.23e-09 | 486 | 106 | 13 | 20936779 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | CRTC3 SEC24A MAML1 ZMIZ1 ARID1A CREBBP RBM20 MEF2D PNPLA6 PKP3 RBM14 TMEM209 | 1.66e-08 | 457 | 106 | 12 | 32344865 |
| Pubmed | 2.32e-08 | 152 | 106 | 8 | 38360978 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | TCF4 MAML1 GATA6 SALL4 CREBBP MEF2C DDIT3 HOXA3 TGFB1I1 JUN FOXB1 RBM14 SMARCD1 PAX1 ZBTB3 | 7.24e-08 | 877 | 106 | 15 | 20211142 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FLNA NIBAN2 MEF2D OTUD7B JUN TLK1 PNPLA6 NFIA PKP3 RBM14 DYNC1LI1 AFDN SRRM2 PCDH7 | 1.04e-07 | 774 | 106 | 14 | 15302935 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXE1 TCF4 ZBTB38 GATA6 CAMTA2 MEF2C MEF2D DDIT3 HOXA3 JUN FOXB1 OTX1 NFIA PAX1 EN1 | 1.13e-07 | 908 | 106 | 15 | 19274049 |
| Pubmed | Interaction network of human early embryonic transcription factors. | SETD1A LIN54 MAML1 ZMIZ1 FLG2 ARID1A CREBBP PBRM1 NFIA SMARCD1 | 1.30e-07 | 351 | 106 | 10 | 38297188 |
| Pubmed | 1.43e-07 | 268 | 106 | 9 | 33640491 | ||
| Pubmed | 1.86e-07 | 199 | 106 | 8 | 36688959 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SETD1A FLNA FRAS1 SHROOM3 PCNX3 MAML1 ARID1A WNK1 JUN TLK1 PNPLA6 DNAJC14 MEGF8 ZNRF3 ENTPD2 TNK2 | 2.45e-07 | 1105 | 106 | 16 | 35748872 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DDR1 SHROOM3 MIA3 ADGRV1 ZMIZ1 CPT1A ARID1A CREBBP CLCC1 MSI2 TLK1 PNPLA6 SHC2 NFIA PKP3 LPP TNK2 CSMD1 | 5.67e-07 | 1489 | 106 | 18 | 28611215 |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 6.90e-07 | 23 | 106 | 4 | 30962207 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 9.04e-07 | 544 | 106 | 11 | 28473536 | |
| Pubmed | Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions. | 1.15e-06 | 110 | 106 | 6 | 37219487 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.40e-06 | 180 | 106 | 7 | 35198878 | |
| Pubmed | 1.52e-06 | 8 | 106 | 3 | 16043483 | ||
| Pubmed | 1.53e-06 | 263 | 106 | 8 | 34702444 | ||
| Pubmed | 1.83e-06 | 29 | 106 | 4 | 19279220 | ||
| Pubmed | FLNA TCF4 CRTC3 COL12A1 PRPF6 CUBN HIBADH MEF2C CLCC1 OTUD7B HOXB7 OTX1 DMKN ELN CSMD1 PRNP | 1.92e-06 | 1293 | 106 | 16 | 15342556 | |
| Pubmed | 2.28e-06 | 9 | 106 | 3 | 9738004 | ||
| Pubmed | 2.28e-06 | 9 | 106 | 3 | 12764108 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CRTC3 SHROOM3 SEC24A WNK1 MEF2D TAB3 MEGF8 LPP RBM14 AFDN SRRM2 PCDH7 USP6NL | 2.29e-06 | 861 | 106 | 13 | 36931259 |
| Pubmed | 3.38e-06 | 503 | 106 | 10 | 16964243 | ||
| Pubmed | 3.48e-06 | 75 | 106 | 5 | 15951569 | ||
| Pubmed | FLNA LIN54 MAML1 PRPF6 ARID1A CREBBP MEF2D JUN TLK1 RBM14 DYNC1LI1 SMARCD1 ZBTB3 SRRM2 | 6.73e-06 | 1103 | 106 | 14 | 34189442 | |
| Pubmed | Galectin-3 regulates the adhesive interaction between breast carcinoma cells and elastin. | 9.20e-06 | 2 | 106 | 2 | 10536372 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 39062631 | ||
| Pubmed | Molecular Pathway to Protection From Age-Dependent Photoreceptor Degeneration in Mef2 Deficiency. | 9.20e-06 | 2 | 106 | 2 | 28738418 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 34779502 | ||
| Pubmed | Spongiform pathology in mouse CNS lacking 'neuropathy target esterase' and cellular prion protein. | 9.20e-06 | 2 | 106 | 2 | 19524041 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 10820253 | ||
| Pubmed | MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients. | 9.20e-06 | 2 | 106 | 2 | 26921792 | |
| Pubmed | Together JUN and DDIT3 (CHOP) control retinal ganglion cell death after axonal injury. | 9.20e-06 | 2 | 106 | 2 | 28969695 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 10435624 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 25427824 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 28472257 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19690385 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 23369722 | ||
| Pubmed | Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. | 9.77e-06 | 14 | 106 | 3 | 8895581 | |
| Pubmed | 1.22e-05 | 15 | 106 | 3 | 15985610 | ||
| Pubmed | Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development. | 1.22e-05 | 15 | 106 | 3 | 19782130 | |
| Pubmed | 1.22e-05 | 15 | 106 | 3 | 17640523 | ||
| Pubmed | 1.29e-05 | 167 | 106 | 6 | 22159717 | ||
| Pubmed | 1.30e-05 | 98 | 106 | 5 | 16783635 | ||
| Pubmed | Mutant Lef1 controls Gata6 in sebaceous gland development and cancer. | 1.50e-05 | 16 | 106 | 3 | 30886049 | |
| Pubmed | LAMB1 WNK1 TGFB1I1 AFAP1L2 MEGF8 ZNRF3 NYNRIN RBM14 GRIP2 PRNP | 1.75e-05 | 608 | 106 | 10 | 16713569 | |
| Pubmed | 1.81e-05 | 17 | 106 | 3 | 11078522 | ||
| Pubmed | 1.81e-05 | 17 | 106 | 3 | 19915572 | ||
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 1.84e-05 | 178 | 106 | 6 | 27637333 | |
| Pubmed | 2.09e-05 | 272 | 106 | 7 | 31010829 | ||
| Pubmed | 2.17e-05 | 18 | 106 | 3 | 14730302 | ||
| Pubmed | 2.57e-05 | 19 | 106 | 3 | 25066234 | ||
| Pubmed | Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. | 2.57e-05 | 19 | 106 | 3 | 12110891 | |
| Pubmed | 2.57e-05 | 19 | 106 | 3 | 18809673 | ||
| Pubmed | MAML1 ARID1A CREBBP PBRM1 MEGF8 NFIA TRIM8 SMARCD1 CTNND2 BSN | 2.64e-05 | 638 | 106 | 10 | 31182584 | |
| Pubmed | 2.74e-05 | 191 | 106 | 6 | 24146773 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 33558447 | ||
| Pubmed | CHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis. | 2.76e-05 | 3 | 106 | 2 | 20430872 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 27936017 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 23328440 | ||
| Pubmed | Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. | 2.76e-05 | 3 | 106 | 2 | 12050117 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 8622660 | ||
| Pubmed | An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. | 2.76e-05 | 3 | 106 | 2 | 18093911 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 28694294 | ||
| Pubmed | The cardiac pacemaker-specific channel Hcn4 is a direct transcriptional target of MEF2. | 2.76e-05 | 3 | 106 | 2 | 19477969 | |
| Pubmed | In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival. | 2.76e-05 | 3 | 106 | 2 | 22496871 | |
| Pubmed | Loss of polarity protein AF6 promotes pancreatic cancer metastasis by inducing Snail expression. | 2.76e-05 | 3 | 106 | 2 | 26013125 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 20650901 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 15743823 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 16285957 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 27989458 | ||
| Pubmed | Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. | 2.76e-05 | 3 | 106 | 2 | 8028671 | |
| Pubmed | Visual Cortex Gains Independence from Peripheral Drive before Eye Opening. | 2.76e-05 | 3 | 106 | 2 | 31561919 | |
| Pubmed | miR-216b regulation of c-Jun mediates GADD153/CHOP-dependent apoptosis. | 2.76e-05 | 3 | 106 | 2 | 27173017 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 24185509 | ||
| Pubmed | The histone chaperone SET/TAF-Ibeta interacts functionally with the CREB-binding protein. | 2.76e-05 | 3 | 106 | 2 | 16061203 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 21807070 | ||
| Pubmed | Cubilin, a binding partner for galectin-3 in the murine utero-placental complex. | 2.76e-05 | 3 | 106 | 2 | 11856751 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 10085123 | ||
| Pubmed | Evaluation of JUN, FN1 and LAMB1 polymorphisms in pterygium in a Chinese Han population. | 2.76e-05 | 3 | 106 | 2 | 35445627 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 12177201 | ||
| Pubmed | Prion replication alters the distribution of synaptophysin and caveolin 1 in neuronal lipid rafts. | 2.76e-05 | 3 | 106 | 2 | 15509552 | |
| Pubmed | The MADS transcription factor Mef2c is a pivotal modulator of myeloid cell fate. | 2.76e-05 | 3 | 106 | 2 | 18326819 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 17410209 | ||
| Pubmed | Adaptor linked K63 di-ubiquitin activates Nedd4/Rsp5 E3 ligase. | 2.76e-05 | 3 | 106 | 2 | 35770973 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 15834131 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 8096059 | ||
| Pubmed | Selectivity of chromatin-remodelling cofactors for ligand-activated transcription. | 2.76e-05 | 3 | 106 | 2 | 11780067 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 26286136 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 32723872 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 2138276 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 33315889 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 17101791 | ||
| Pubmed | Essential control of early B-cell development by Mef2 transcription factors. | 2.76e-05 | 3 | 106 | 2 | 26660426 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 26924460 | ||
| Pubmed | 3.08e-05 | 195 | 106 | 6 | 19454010 | ||
| Pubmed | 3.72e-05 | 61 | 106 | 4 | 20305087 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 3.86e-05 | 203 | 106 | 6 | 22083510 | |
| Interaction | TLE3 interactions | FLNA TCF4 CRTC3 SEC24A MAML1 ZMIZ1 ARID1A CREBBP RBM20 FOXB1 NFIA RBM14 EN1 SRRM2 | 9.60e-09 | 376 | 105 | 14 | int:TLE3 |
| Interaction | KLF5 interactions | 7.42e-08 | 195 | 105 | 10 | int:KLF5 | |
| Interaction | NUP35 interactions | CRTC3 SEC24A MAML1 ZMIZ1 ARID1A CREBBP RBM20 MEF2D PNPLA6 PKP3 RBM14 TMEM209 AFDN | 3.18e-07 | 424 | 105 | 13 | int:NUP35 |
| Interaction | SOX10 interactions | 5.19e-07 | 92 | 105 | 7 | int:SOX10 | |
| Interaction | SP7 interactions | LIN54 MAML1 ZMIZ1 ARID1A CREBBP RBM20 MEF2D PBRM1 NFIA SMARCD1 PCDH7 | 5.44e-07 | 304 | 105 | 11 | int:SP7 |
| Interaction | SMAD3 interactions | FLNA DDR1 RANBP9 ZMIZ1 ARID1A CREBBP TGFB1I1 USP2 JUN NFIA RBM14 ZBTB3 PRNP | 5.79e-07 | 447 | 105 | 13 | int:SMAD3 |
| Interaction | PAX8 interactions | 1.85e-06 | 111 | 105 | 7 | int:PAX8 | |
| Interaction | EP300 interactions | SETD1A FLNA TCF4 FRAS1 SEC24A MAML1 GATA6 PRPF6 ARID1A CREBBP MEF2C MEF2D DDIT3 TGFB1I1 JUN HOXB7 NFIA RBM14 TNK2 BSN EN1 SRRM2 | 2.60e-06 | 1401 | 105 | 22 | int:EP300 |
| Interaction | DDIT3 interactions | 3.13e-06 | 120 | 105 | 7 | int:DDIT3 | |
| Interaction | AR interactions | FLNA TCF4 LIN54 RANBP9 MAML1 PRPF6 ZMIZ1 ARID1A CREBBP MEF2D TGFB1I1 USP2 JUN PBRM1 NFIA RBM14 SMARCD1 TNK2 | 3.42e-06 | 992 | 105 | 18 | int:AR |
| Interaction | TLX1 interactions | 3.75e-06 | 175 | 105 | 8 | int:TLX1 | |
| Interaction | TEAD1 interactions | 3.91e-06 | 176 | 105 | 8 | int:TEAD1 | |
| Interaction | SOX7 interactions | 4.40e-06 | 82 | 105 | 6 | int:SOX7 | |
| Interaction | LHX3 interactions | 5.66e-06 | 185 | 105 | 8 | int:LHX3 | |
| Interaction | HNF1B interactions | 6.88e-06 | 190 | 105 | 8 | int:HNF1B | |
| Interaction | MYOD1 interactions | 8.02e-06 | 194 | 105 | 8 | int:MYOD1 | |
| Interaction | NFIB interactions | 9.52e-06 | 142 | 105 | 7 | int:NFIB | |
| Interaction | GATA4 interactions | FOXE1 GATA6 SALL4 PRPF6 ARID1A MEF2C RBM14 SMARCD1 ZBTB3 SRRM2 PRNP | 9.93e-06 | 411 | 105 | 11 | int:GATA4 |
| Interaction | FEV interactions | 1.12e-05 | 203 | 105 | 8 | int:FEV | |
| Interaction | SMARCA2 interactions | 1.33e-05 | 346 | 105 | 10 | int:SMARCA2 | |
| Interaction | SMARCD1 interactions | 1.43e-05 | 349 | 105 | 10 | int:SMARCD1 | |
| Interaction | CTNNB1 interactions | TCF4 SHROOM3 PRPF6 ZMIZ1 CREBBP LGALS3 OTUD7B SLC6A4 USP2 JUN FOXB1 PKP3 RBM14 AFDN CTNND2 SRRM2 USP6NL | 1.74e-05 | 1009 | 105 | 17 | int:CTNNB1 |
| Interaction | SMARCD3 interactions | 2.04e-05 | 107 | 105 | 6 | int:SMARCD3 | |
| Interaction | SMAD4 interactions | SEC24A GATA6 ZMIZ1 CREBBP TGFB1I1 SMG8 JUN NFIA DMKN PKP3 RBM14 PRNP | 2.05e-05 | 530 | 105 | 12 | int:SMAD4 |
| Interaction | ERG interactions | 2.20e-05 | 223 | 105 | 8 | int:ERG | |
| Interaction | LHX4 interactions | 2.62e-05 | 166 | 105 | 7 | int:LHX4 | |
| Interaction | TBR1 interactions | 2.79e-05 | 113 | 105 | 6 | int:TBR1 | |
| Interaction | PPARG interactions | 3.28e-05 | 307 | 105 | 9 | int:PPARG | |
| Interaction | SMAD2 interactions | 3.32e-05 | 385 | 105 | 10 | int:SMAD2 | |
| Interaction | MAML1 interactions | 3.95e-05 | 73 | 105 | 5 | int:MAML1 | |
| Interaction | EYA4 interactions | 4.06e-05 | 243 | 105 | 8 | int:EYA4 | |
| Interaction | ETS1 interactions | 4.10e-05 | 121 | 105 | 6 | int:ETS1 | |
| Interaction | NR3C1 interactions | RANBP9 MAML1 ARID1A CREBBP TGFB1I1 USP2 JUN PBRM1 MEGF8 NFIA RBM14 TRIM8 SMARCD1 CTNND2 BSN ZBTB3 | 4.29e-05 | 974 | 105 | 16 | int:NR3C1 |
| Interaction | SORBS1 interactions | 4.49e-05 | 123 | 105 | 6 | int:SORBS1 | |
| Interaction | PAX7 interactions | 4.70e-05 | 124 | 105 | 6 | int:PAX7 | |
| Interaction | LHX2 interactions | 4.88e-05 | 183 | 105 | 7 | int:LHX2 | |
| Interaction | XAGE1A interactions | 6.07e-05 | 41 | 105 | 4 | int:XAGE1A | |
| Interaction | PSG8 interactions | 6.07e-05 | 41 | 105 | 4 | int:PSG8 | |
| Interaction | PAX9 interactions | 6.13e-05 | 130 | 105 | 6 | int:PAX9 | |
| Interaction | NKX2-5 interactions | 6.92e-05 | 82 | 105 | 5 | int:NKX2-5 | |
| Interaction | RNF43 interactions | 7.89e-05 | 427 | 105 | 10 | int:RNF43 | |
| Interaction | YWHAE interactions | FLNA CRTC3 SHROOM3 SEC24A COL6A5 WNK1 HIBADH TAB3 RIN1 TLK1 RBM14 DYNC1LI1 AFDN SCPEP1 SRRM2 PCDH7 USP6NL PRNP | 8.05e-05 | 1256 | 105 | 18 | int:YWHAE |
| Interaction | IRF4 interactions | 8.22e-05 | 85 | 105 | 5 | int:IRF4 | |
| Interaction | NFATC2 interactions | 8.55e-05 | 200 | 105 | 7 | int:NFATC2 | |
| Interaction | MAML2 interactions | 8.86e-05 | 17 | 105 | 3 | int:MAML2 | |
| Interaction | FLT4 interactions | 8.95e-05 | 272 | 105 | 8 | int:FLT4 | |
| Interaction | SMARCC2 interactions | 9.62e-05 | 353 | 105 | 9 | int:SMARCC2 | |
| Interaction | SS18 interactions | 9.70e-05 | 88 | 105 | 5 | int:SS18 | |
| Interaction | CALR3 interactions | 9.99e-05 | 142 | 105 | 6 | int:CALR3 | |
| Interaction | NFIC interactions | 1.16e-04 | 210 | 105 | 7 | int:NFIC | |
| Interaction | SOX2 interactions | FLNA PCNX3 LIN54 RANBP9 MAML1 SALL4 ARID1A MEF2C MEF2D MSI2 OTUD7B JUN PBRM1 NFIA DMKN PKP3 RBM14 PRICKLE2 SMARCD1 | 1.26e-04 | 1422 | 105 | 19 | int:SOX2 |
| Interaction | AXL interactions | 1.34e-04 | 369 | 105 | 9 | int:AXL | |
| Interaction | SOX17 interactions | 1.39e-04 | 95 | 105 | 5 | int:SOX17 | |
| Interaction | SOX9 interactions | 1.54e-04 | 97 | 105 | 5 | int:SOX9 | |
| Interaction | SS18L1 interactions | 1.61e-04 | 98 | 105 | 5 | int:SS18L1 | |
| Interaction | SMARCC1 interactions | 1.81e-04 | 384 | 105 | 9 | int:SMARCC1 | |
| Interaction | YWHAH interactions | CRTC3 SHROOM3 SEC24A PRPF6 WNK1 CREBBP MEF2D TAB3 RIN1 JUN MEGF8 LPP RBM14 AFDN SRRM2 USP6NL | 1.81e-04 | 1102 | 105 | 16 | int:YWHAH |
| Interaction | NFIX interactions | 1.87e-04 | 227 | 105 | 7 | int:NFIX | |
| Interaction | TPRX2 interactions | 2.07e-04 | 56 | 105 | 4 | int:TPRX2 | |
| Interaction | UCN3 interactions | 2.26e-04 | 23 | 105 | 3 | int:UCN3 | |
| Interaction | DRD1 interactions | 2.26e-04 | 23 | 105 | 3 | int:DRD1 | |
| Interaction | POU5F1 interactions | FLNA TCF4 LAMB1 SALL4 CUBN ARID1A PBRM1 P3H1 RBM14 DYNC1LI1 AFDN | 2.34e-04 | 584 | 105 | 11 | int:POU5F1 |
| Interaction | NFATC1 interactions | 2.50e-04 | 168 | 105 | 6 | int:NFATC1 | |
| Interaction | EWSR1 interactions | CRTC3 MIA3 SEC24A RANBP9 MAML1 GATA6 SALL4 PRPF6 ARID1A CREBBP DDIT3 JUN OTX1 TRIM8 | 2.54e-04 | 906 | 105 | 14 | int:EWSR1 |
| Interaction | ENTPD8 interactions | 2.66e-04 | 5 | 105 | 2 | int:ENTPD8 | |
| Interaction | FOXM1 interactions | 3.13e-04 | 113 | 105 | 5 | int:FOXM1 | |
| Interaction | ARID3B interactions | 3.13e-04 | 113 | 105 | 5 | int:ARID3B | |
| Interaction | NTRK2 interactions | 3.21e-04 | 176 | 105 | 6 | int:NTRK2 | |
| Interaction | GPRASP3 interactions | 3.27e-04 | 63 | 105 | 4 | int:GPRASP3 | |
| Interaction | ARID1B interactions | 3.31e-04 | 177 | 105 | 6 | int:ARID1B | |
| Interaction | TBXT interactions | 3.54e-04 | 116 | 105 | 5 | int:TBXT | |
| Interaction | ROR2 interactions | 3.55e-04 | 333 | 105 | 8 | int:ROR2 | |
| Interaction | AFDN interactions | 3.55e-04 | 333 | 105 | 8 | int:AFDN | |
| Interaction | BRD9 interactions | 3.68e-04 | 117 | 105 | 5 | int:BRD9 | |
| Interaction | CRX interactions | 3.71e-04 | 254 | 105 | 7 | int:CRX | |
| Interaction | USP42 interactions | 3.91e-04 | 66 | 105 | 4 | int:USP42 | |
| Interaction | NCR3 interactions | 4.14e-04 | 120 | 105 | 5 | int:NCR3 | |
| Interaction | NUP50 interactions | 4.15e-04 | 341 | 105 | 8 | int:NUP50 | |
| Interaction | SIRT6 interactions | SETD1A FLNA MIA3 PRPF6 ARID1A CREBBP SMG8 PBRM1 TMEM209 SMARCD1 PCDH7 | 4.33e-04 | 628 | 105 | 11 | int:SIRT6 |
| Interaction | GCM1 interactions | 4.39e-04 | 68 | 105 | 4 | int:GCM1 | |
| Interaction | ATG5 interactions | 4.40e-04 | 344 | 105 | 8 | int:ATG5 | |
| Interaction | GATA3 interactions | 4.43e-04 | 187 | 105 | 6 | int:GATA3 | |
| Interaction | NOTCH1 interactions | 4.49e-04 | 345 | 105 | 8 | int:NOTCH1 | |
| Interaction | COL11A1 interactions | 4.55e-04 | 29 | 105 | 3 | int:COL11A1 | |
| Interaction | NFIA interactions | 4.56e-04 | 188 | 105 | 6 | int:NFIA | |
| Interaction | FGFR1 interactions | MIA3 SEC24A NIBAN2 CREBBP CLCC1 RIN1 LPP TMEM209 TNK2 PCDH7 USP6NL | 4.57e-04 | 632 | 105 | 11 | int:FGFR1 |
| Interaction | ETV4 interactions | 4.64e-04 | 69 | 105 | 4 | int:ETV4 | |
| Interaction | DPF2 interactions | 4.84e-04 | 349 | 105 | 8 | int:DPF2 | |
| Interaction | FMR1 interactions | 4.90e-04 | 536 | 105 | 10 | int:FMR1 | |
| Interaction | NEGR1 interactions | 5.04e-04 | 30 | 105 | 3 | int:NEGR1 | |
| Interaction | CFC1 interactions | 5.17e-04 | 126 | 105 | 5 | int:CFC1 | |
| Interaction | PIAS1 interactions | 5.22e-04 | 353 | 105 | 8 | int:PIAS1 | |
| Interaction | SYNE3 interactions | 5.24e-04 | 444 | 105 | 9 | int:SYNE3 | |
| Interaction | TOP3B interactions | SETD1A FLNA FRAS1 SHROOM3 PCNX3 SEC24A MAML1 ARID1A WNK1 JUN TLK1 PNPLA6 DNAJC14 MEGF8 ZNRF3 ENTPD2 RBM14 TNK2 | 5.57e-04 | 1470 | 105 | 18 | int:TOP3B |
| Interaction | HNF4A interactions | 5.95e-04 | 275 | 105 | 7 | int:HNF4A | |
| Interaction | ARID1A interactions | 6.08e-04 | 276 | 105 | 7 | int:ARID1A | |
| Interaction | BEND5 interactions | 6.11e-04 | 32 | 105 | 3 | int:BEND5 | |
| Interaction | GATA2 interactions | 6.15e-04 | 199 | 105 | 6 | int:GATA2 | |
| Interaction | PAX6 interactions | 6.61e-04 | 366 | 105 | 8 | int:PAX6 | |
| Interaction | NXPH2 interactions | 6.69e-04 | 33 | 105 | 3 | int:NXPH2 | |
| Cytoband | 17q22 | 1.48e-04 | 44 | 106 | 3 | 17q22 | |
| Cytoband | 11q13.2 | 1.80e-04 | 47 | 106 | 3 | 11q13.2 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 8.08e-05 | 4 | 67 | 2 | 649 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 1.34e-04 | 5 | 67 | 2 | 1086 | |
| GeneFamily | LIM domain containing | 1.36e-03 | 59 | 67 | 3 | 1218 | |
| GeneFamily | PDZ domain containing | 2.44e-03 | 152 | 67 | 4 | 1220 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | FOXE1 COL12A1 GATA6 LAMB1 LGALS3 HOXA3 JUN FOXB1 HOXB7 OTX1 NFIA CD34 ENTPD2 ENTPD3 PAX1 CTNND2 CSMD1 EN1 | 5.07e-07 | 1115 | 106 | 18 | M10371 |
| Coexpression | HOSHIDA_LIVER_CANCER_SURVIVAL_UP | 5.18e-07 | 73 | 106 | 6 | M6939 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | TCF4 ZBTB38 PHLDA1 LAMB1 CPT1A MEF2C MEF2D DDIT3 RASIP1 JUN AFAP1L2 CD34 LPP PRICKLE2 ELN | 2.90e-06 | 888 | 106 | 15 | M39049 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | TCF4 COL12A1 PAMR1 LAMB1 MEF2C TGFB1I1 RASIP1 P3H1 PRICKLE2 PCDH7 PRNP | 3.95e-06 | 479 | 106 | 11 | M2573 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | TCF4 COL12A1 PAMR1 LAMB1 MEF2C TGFB1I1 RASIP1 P3H1 PRICKLE2 PCDH7 PRNP | 4.28e-06 | 483 | 106 | 11 | MM1082 |
| Coexpression | BENPORATH_EED_TARGETS | FOXE1 COL12A1 GATA6 ARID1A LGALS3 HOXA3 JUN FOXB1 HOXB7 OTX1 CD34 PAX1 CTNND2 CSMD1 EN1 SRRM2 | 5.46e-06 | 1059 | 106 | 16 | M7617 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | EPOR FRAS1 GATA6 LAMB1 SALL4 ADGRV1 DDIT3 USP2 JUN ENTPD3 CTNND2 | 6.40e-06 | 504 | 106 | 11 | M2157 |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 6.70e-06 | 65 | 106 | 5 | M39309 | |
| Coexpression | AIGNER_ZEB1_TARGETS | 1.20e-05 | 35 | 106 | 4 | M14590 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 1.26e-05 | 126 | 106 | 6 | M39132 | |
| Coexpression | BENPORATH_PRC2_TARGETS | FOXE1 GATA6 LGALS3 JUN FOXB1 HOXB7 OTX1 CD34 PAX1 CTNND2 CSMD1 EN1 | 1.29e-05 | 650 | 106 | 12 | M8448 |
| Coexpression | GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP | 1.69e-05 | 199 | 106 | 7 | M8119 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | FLNA ZBTB38 PAMR1 PHLDA1 LAMB1 CPT1A MEF2C MEF2D DDIT3 JUN AFAP1L2 LPP SCPEP1 | 1.98e-05 | 795 | 106 | 13 | M39050 |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 2.11e-05 | 206 | 106 | 7 | M2817 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 2.25e-05 | 208 | 106 | 7 | MM581 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 3.31e-05 | 221 | 106 | 7 | M39222 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | TCF4 ZFP90 PHLDA1 LAMB1 DDIT3 MSI2 HOXA3 USP2 JUN NPTXR CD34 LPP | 3.56e-05 | 721 | 106 | 12 | M1999 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MIA3 ZBTB38 LIN54 SALL4 ZMIZ1 NPTXR PRICKLE2 SYP TNK2 GRIP2 CTNND2 CSMD1 BSN PCDH7 PRNP | 3.87e-05 | 1106 | 106 | 15 | M39071 |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 7.61e-05 | 440 | 106 | 9 | M39039 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 8.50e-05 | 177 | 106 | 6 | M39245 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_STROMAL_CELL_AGEING | 8.86e-05 | 349 | 106 | 8 | MM3790 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | SETD1A FLNA DDR1 MIA3 PCNX3 LAMB1 ARID1A MFSD14A ZNRF3 NPTXR CD34 | 9.99e-05 | 681 | 106 | 11 | M5314 |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 1.15e-04 | 117 | 106 | 5 | M39300 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | SETD1A FLNA DDR1 MIA3 PCNX3 LAMB1 ARID1A MFSD14A ZNRF3 NPTXR CD34 | 1.32e-04 | 703 | 106 | 11 | MM1055 |
| Coexpression | GSE3982_BCELL_VS_TH2_UP | 1.53e-04 | 197 | 106 | 6 | M5554 | |
| Coexpression | NUYTTEN_NIPP1_TARGETS_DN | DDR1 ZBTB38 PHLDA1 KREMEN2 RANBP9 CPT1A ARID1A TAB3 LPP ENTPD3 TRIM8 SCPEP1 | 1.60e-04 | 845 | 106 | 12 | M18090 |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_UP | 1.61e-04 | 199 | 106 | 6 | M8115 | |
| Coexpression | GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN | 1.61e-04 | 199 | 106 | 6 | M8388 | |
| Coexpression | GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_UP | 1.61e-04 | 199 | 106 | 6 | M4148 | |
| Coexpression | GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_UP | 1.66e-04 | 200 | 106 | 6 | M6398 | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 1.66e-04 | 200 | 106 | 6 | M291 | |
| Coexpression | GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN | 1.66e-04 | 200 | 106 | 6 | M5286 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_DN | 1.66e-04 | 200 | 106 | 6 | M9925 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_DN | 1.66e-04 | 200 | 106 | 6 | M3973 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 1.74e-04 | 385 | 106 | 8 | M39264 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ADVENTITIAL_FIBROBLAST | 1.99e-04 | 71 | 106 | 4 | M45664 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_ENDOTHELIAL_CELLS | 2.41e-04 | 137 | 106 | 5 | M41743 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | FOXE1 GATA6 LGALS3 JUN FOXB1 HOXB7 OTX1 NFIA CD34 PAX1 CTNND2 CSMD1 EN1 | 2.80e-04 | 1035 | 106 | 13 | M9898 |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 3.05e-04 | 316 | 106 | 7 | M2293 | |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | TCF4 FRAS1 SHROOM3 GATA6 CPT1A JUN PRICKLE2 SCPEP1 CTNND2 SRRM2 PCDH7 | 3.44e-04 | 786 | 106 | 11 | M10961 |
| Coexpression | BHAT_ESR1_TARGETS_VIA_AKT1_DN | 3.47e-04 | 82 | 106 | 4 | M2235 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 3.48e-04 | 323 | 106 | 7 | MM1066 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | PAMR1 PHLDA1 GATA6 LAMB1 JUN NFIA CD34 ENTPD2 SCPEP1 ELN CSMD1 PCDH7 PRNP | 5.77e-07 | 466 | 106 | 13 | GSM777050_500 |
| CoexpressionAtlas | Myeloid Cells, DC.LC.Sk, MHCII+ CD11b+ CD45+, Skin, avg-2 | PHLDA1 NIBAN2 LGALS3 SLC6A4 JUN AFAP1L2 DMKN AFDN CTNND2 PCDH7 PRNP | 1.59e-05 | 451 | 106 | 11 | GSM538280_500 |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | COL12A1 PAMR1 PHLDA1 LAMB1 COL6A5 JUN AFAP1L2 CD34 ELN PCDH7 PRNP | 1.66e-05 | 453 | 106 | 11 | GSM777067_500 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.58e-05 | 249 | 106 | 8 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.87e-05 | 184 | 106 | 7 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k2 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 9.41e-05 | 455 | 106 | 10 | GSM777055_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | COL12A1 PAMR1 SEC24A LGALS3 TGFB1I1 NFIA DMKN ENTPD2 LPP ENTPD3 ELN CTNND2 PCDH7 | 1.24e-04 | 772 | 106 | 13 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_1000 | COL12A1 PAMR1 CPT1A LGALS3 MSI2 NFIA DMKN CD34 ENTPD2 LPP ENTPD3 ELN PCDH7 | 1.27e-04 | 774 | 106 | 13 | gudmap_developingLowerUrinaryTract_P1_ureter_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.53e-04 | 229 | 106 | 7 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.87e-04 | 166 | 106 | 6 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000_K3 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.Sp, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Spleen, avg-1 | 2.23e-04 | 412 | 106 | 9 | GSM605839_500 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.50e-08 | 185 | 106 | 8 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery|Adult / Lineage, Cell type, age group and donor | 1.57e-08 | 186 | 106 | 8 | 2d1c4ea2e401db89971582ee54618a8b0c81b8ac | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.17e-08 | 194 | 106 | 8 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-08 | 194 | 106 | 8 | 9709dc95fb6982b6a0467b507845d5bc17252e3e | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-08 | 194 | 106 | 8 | 93b7a9065430740ec31fce4e8c14ffccb498591d | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-08 | 194 | 106 | 8 | 0d2e65b44e3f143971c2fd24c4552f042b049cfa | |
| ToppCell | P15-Mesenchymal-myocytic_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.35e-08 | 196 | 106 | 8 | 41ae5b0d81ad09a6663335d899b4a1e4976c3b62 | |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.65e-08 | 199 | 106 | 8 | 3368c0a90a47c4dcdfe70be3192550df0744e508 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-07 | 171 | 106 | 7 | 121e63ca281ad765d76c2afb3b4d441329b47f81 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-07 | 173 | 106 | 7 | fc2602b2ce051cd4c33957d7e3d041ff8a529883 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-07 | 173 | 106 | 7 | 901b8e6909c1f3849906fad9cee17b8f0bab050d | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-07 | 185 | 106 | 7 | 01bbe1e09f9ccae837a03ea2cdd168fa10800942 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-07 | 186 | 106 | 7 | d65fa6d8e8a195ea10cfde1499d096d6acf7a634 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-07 | 188 | 106 | 7 | e54e09d34e263d5709c337914809e61e74e20591 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-07 | 188 | 106 | 7 | 7fc9810ab14354cb512e2b1285562009c10203f5 | |
| ToppCell | 15-Airway-Epithelial-Basal_cell|Airway / Age, Tissue, Lineage and Cell class | 3.54e-07 | 189 | 106 | 7 | f128c2fc37f232d193de18a922c47fdd70e1982d | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.67e-07 | 190 | 106 | 7 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.67e-07 | 190 | 106 | 7 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | Fibroblast-D_(Pericyte)|World / shred on cell class and cell subclass (v4) | 3.94e-07 | 192 | 106 | 7 | 8c13c351fcc3d88e8c2ffa017e71ff6272cc6fac | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-07 | 194 | 106 | 7 | 775600880bb77781de48085d8744c1030223de1f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.23e-07 | 194 | 106 | 7 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-07 | 194 | 106 | 7 | 04ecb609d233a4b12e275c604810937830363e17 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.37e-07 | 195 | 106 | 7 | 6e875c83f838241b5fcaf4a3249b1408d74521dc | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-07 | 196 | 106 | 7 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-07 | 196 | 106 | 7 | 65f2f51e17f1869f3468813127b96d3048d8ad41 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-07 | 196 | 106 | 7 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-07 | 196 | 106 | 7 | e4ed897900a6472738bc6be2fb4817192727225d | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-07 | 196 | 106 | 7 | 2cd83176f2e8a9e6fa3c08cb33928a61e5fc43b6 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.85e-07 | 198 | 106 | 7 | b258f672529fb2c03e62e2696d335043c4963280 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.85e-07 | 198 | 106 | 7 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_3|COVID-19_Severe / Disease condition and Cell class | 5.01e-07 | 199 | 106 | 7 | ffb2ef9b7006cbed0f43637af040719b9776cbd5 | |
| ToppCell | 3'-GW_trimst-1.5|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.01e-07 | 199 | 106 | 7 | 8e69d718ed5b05b08550973c33c92f0c6bfccc68 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.19e-07 | 200 | 106 | 7 | a637281d91e95734ee4f8510b3780e0272b16fda | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.19e-07 | 200 | 106 | 7 | c0ea7cbc9d5e999530888145ce9e4c232fc874de | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.61e-06 | 163 | 106 | 6 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 2.70e-06 | 164 | 106 | 6 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 3.10e-06 | 168 | 106 | 6 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-06 | 170 | 106 | 6 | 29deb285d5a82c0abcc108012ca42f4b4b4d9e19 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-basal_late|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.32e-06 | 170 | 106 | 6 | 83320d37f0fc74e492cfe3de18f5c499eaa9fd3e | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-06 | 170 | 106 | 6 | dc35d66a9a9fe6cdd7f4ec0fe7efa49d02f2b5b2 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-06 | 173 | 106 | 6 | 1b9b4e165121b08ef15a93fca6bea875cae69f19 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-06 | 173 | 106 | 6 | c25f24d7b672c9686d31ebc8d263042282f520fd | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.80e-06 | 174 | 106 | 6 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-06 | 176 | 106 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.19e-06 | 177 | 106 | 6 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.33e-06 | 178 | 106 | 6 | e2363810d77b6b245394a666eb51bacd345c43f7 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-06 | 179 | 106 | 6 | 1757b9f3f4c634277a67c4f5a39d27d6b4937073 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.62e-06 | 180 | 106 | 6 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-06 | 180 | 106 | 6 | 64f01494a4052186773720e10b4e7c724ff94547 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.08e-06 | 183 | 106 | 6 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.08e-06 | 183 | 106 | 6 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-06 | 184 | 106 | 6 | 9690d4290e70f9bda889754ffb30b0af1f7cb94b | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | 5.24e-06 | 184 | 106 | 6 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.41e-06 | 185 | 106 | 6 | 808d5e880069aff8866cd2c733b9fe568a37701f | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.41e-06 | 185 | 106 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-06 | 185 | 106 | 6 | 65dcb0a7ee64990a34a87c167b44497107f035ee | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.57e-06 | 186 | 106 | 6 | 08632045d499e61dd96ff29a5a9a208afe58dc58 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.57e-06 | 186 | 106 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.57e-06 | 186 | 106 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.57e-06 | 186 | 106 | 6 | b3358e0fa6d845c81e94d56c8575f016621d28ff | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.75e-06 | 187 | 106 | 6 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.75e-06 | 187 | 106 | 6 | 401be371b32066db926de3415bb4ce9465749dc3 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.75e-06 | 187 | 106 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.93e-06 | 188 | 106 | 6 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.93e-06 | 188 | 106 | 6 | 6ec22b79b19d57ea187f312907819dc2d01f3efe | |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-06 | 189 | 106 | 6 | c3fb363bb0156ffb3367c200f548faebda64ab4a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-06 | 189 | 106 | 6 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-06 | 189 | 106 | 6 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-06 | 189 | 106 | 6 | bc54ffd7bd1627a36747a80ce5139e4a69928400 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-06 | 190 | 106 | 6 | 3720e64129f3f3268b1dc14031a76f41c38241c2 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.30e-06 | 190 | 106 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-06 | 190 | 106 | 6 | 73a50426f972f08f9bb525ad5c0b774187ab5d6a | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-06 | 190 | 106 | 6 | f3ca94a31a35eed5fecf3c4b8c957e1bc4150158 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-06 | 190 | 106 | 6 | b55cf1fb586b724295b7b038483249847bb344fc | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.30e-06 | 190 | 106 | 6 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-06 | 190 | 106 | 6 | c2cd1eb674162ee40502c3380b7245c85079c7ce | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-06 | 190 | 106 | 6 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | facs-Skin|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 191 | 106 | 6 | ae524103331fa53fa82888dbb567fc36abcee7e0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-06 | 191 | 106 | 6 | 0a0719a0a49ae0099d61e22585ac74c10c24b4a2 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 191 | 106 | 6 | 9fc674a58f20b47255e4457d5195c8cff17b0414 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.49e-06 | 191 | 106 | 6 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.49e-06 | 191 | 106 | 6 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 191 | 106 | 6 | c379a499dabf3c9ed80f47adbb2d949821c5b053 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.69e-06 | 192 | 106 | 6 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.69e-06 | 192 | 106 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | facs-Trachea-nan-18m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-06 | 192 | 106 | 6 | f388a336062880609724e91bf51bd0f9c4da2f69 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.69e-06 | 192 | 106 | 6 | 0e7e55505bd5454d7cf952a63fdcb46ec76f1973 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.69e-06 | 192 | 106 | 6 | 26d9207e72bbef5e0046de511e2c9ff752b726f3 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-06 | 192 | 106 | 6 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | facs-Trachea-nan-18m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-06 | 192 | 106 | 6 | ceadfbce037bef15523916ba091bb6c0d752cce5 | |
| ToppCell | P28-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.69e-06 | 192 | 106 | 6 | 87c7780cf72f4c204f2a5f6655309d47a23c08ae | |
| ToppCell | (3)_Chondrocytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.69e-06 | 192 | 106 | 6 | 5d2b4830d025d3dbdf5623ce1c28d1036e1984a8 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 6.69e-06 | 192 | 106 | 6 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-06 | 192 | 106 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.89e-06 | 193 | 106 | 6 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 6.89e-06 | 193 | 106 | 6 | e1de67ddada87229f5db0ec193a6da8745a86a64 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.89e-06 | 193 | 106 | 6 | 3316d6a39abb6a518d45b846254325fc7a8b2035 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.89e-06 | 193 | 106 | 6 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-06 | 193 | 106 | 6 | 733f557bdc80293b40ccdf560f1675793df932d6 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.89e-06 | 193 | 106 | 6 | 96c85b250d04b5f400512097d925061c6dc2906b | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 1.34e-07 | 177 | 105 | 9 | 1645_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.35e-06 | 172 | 105 | 8 | 1072_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.47e-06 | 174 | 105 | 8 | 1659_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.98e-06 | 181 | 105 | 8 | 6951_DN | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 3.19e-06 | 193 | 105 | 8 | 2829_UP | |
| Drug | Cyclizine hydrochloride [303-25-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 3.31e-06 | 194 | 105 | 8 | 2880_DN | |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 3.85e-06 | 198 | 105 | 8 | 7437_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.41e-05 | 170 | 105 | 7 | 1050_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.52e-05 | 172 | 105 | 7 | 3428_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.76e-05 | 176 | 105 | 7 | 6932_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.76e-05 | 176 | 105 | 7 | 981_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.83e-05 | 177 | 105 | 7 | 6434_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.83e-05 | 177 | 105 | 7 | 5308_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.83e-05 | 177 | 105 | 7 | 3227_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.90e-05 | 178 | 105 | 7 | 1112_DN | |
| Drug | Methamphetamine | FOXE1 EPOR FLNA TCF4 PCNX3 SEC24A LIN54 CAMTA2 CUBN ARID1A RBM20 DDIT3 SLC6A4 JUN DMKN SYP GRIP2 CSMD1 SRRM2 | 2.00e-05 | 1401 | 105 | 19 | ctd:D008694 |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.04e-05 | 180 | 105 | 7 | 5511_DN | |
| Drug | Ursolic acid [77-52-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 2.19e-05 | 182 | 105 | 7 | 2230_UP | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 2.35e-05 | 184 | 105 | 7 | 6939_DN | |
| Drug | valinomycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.43e-05 | 185 | 105 | 7 | 5906_UP | |
| Drug | SureCN1470880 | 2.64e-05 | 13 | 105 | 3 | CID011486945 | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.69e-05 | 188 | 105 | 7 | 4405_UP | |
| Drug | Econazole nitrate [24169-02-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.98e-05 | 191 | 105 | 7 | 6008_UP | |
| Drug | Conessine [546-06-5]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.29e-05 | 194 | 105 | 7 | 2792_DN | |
| Drug | ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A | 3.29e-05 | 194 | 105 | 7 | 7534_DN | |
| Drug | Pyrazinamide [ 98-96-4]; Down 200; 32.4uM; HL60; HT_HG-U133A | 3.40e-05 | 195 | 105 | 7 | 2478_DN | |
| Drug | Mesoridazine besylate [32672-69-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 3.52e-05 | 196 | 105 | 7 | 2874_DN | |
| Drug | 6-mercaptopurine monohydrate; Up 200; 10uM; PC3; HG-U133A | 3.52e-05 | 196 | 105 | 7 | 667_UP | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 1uM; PC3; HT_HG-U133A | 3.52e-05 | 196 | 105 | 7 | 4291_UP | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 3.63e-05 | 197 | 105 | 7 | 5276_UP | |
| Drug | Scopolamine hydrochloride [55-16-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 3.63e-05 | 197 | 105 | 7 | 3357_UP | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Up 200; 7uM; MCF7; HT_HG-U133A | 3.63e-05 | 197 | 105 | 7 | 3209_UP | |
| Drug | ST021200; Down 200; 10uM; MCF7; HT_HG-U133A | 3.75e-05 | 198 | 105 | 7 | 7554_DN | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A | 3.75e-05 | 198 | 105 | 7 | 4301_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 3.75e-05 | 198 | 105 | 7 | 6983_DN | |
| Drug | Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 3.87e-05 | 199 | 105 | 7 | 6836_DN | |
| Drug | Protoveratrine A [143-57-7]; Up 200; 5uM; PC3; HT_HG-U133A | 3.87e-05 | 199 | 105 | 7 | 6618_UP | |
| Drug | semustine; Down 200; 100uM; MCF7; HT_HG-U133A | 3.87e-05 | 199 | 105 | 7 | 7487_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A | 4.00e-05 | 200 | 105 | 7 | 1666_DN | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; HL60; HG-U133A | 4.00e-05 | 200 | 105 | 7 | 2027_DN | |
| Drug | Nifedipine [21829-25-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 4.00e-05 | 200 | 105 | 7 | 1692_UP | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 4.14e-05 | 83 | 105 | 5 | CID011968896 | |
| Drug | CLPFs | 6.30e-05 | 3 | 105 | 2 | CID000060642 | |
| Drug | Azaguanine-8 [134-58-7]; Up 200; 26.2uM; HL60; HT_HG-U133A | 9.61e-05 | 159 | 105 | 6 | 1833_UP | |
| Drug | Cocaine | TCF4 FRAS1 LAMB1 CREBBP MEF2D DDIT3 SLC6A4 JUN NPTXR ENTPD2 ENTPD3 RBM14 PRICKLE2 SYP GRIP2 CTNND2 PCDH7 | 1.03e-04 | 1314 | 105 | 17 | ctd:D003042 |
| Drug | nitrofen | 1.16e-04 | 237 | 105 | 7 | ctd:C007350 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.34e-04 | 169 | 105 | 6 | 6064_DN | |
| Drug | Niclosamide [50-65-7]; Up 200; 12.2uM; HL60; HG-U133A | 1.48e-04 | 172 | 105 | 6 | 1998_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.48e-04 | 172 | 105 | 6 | 2794_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.57e-04 | 174 | 105 | 6 | 3462_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.62e-04 | 175 | 105 | 6 | 3787_DN | |
| Drug | C15H20O3 | 1.62e-04 | 175 | 105 | 6 | CID000004692 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.67e-04 | 176 | 105 | 6 | 6784_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.67e-04 | 176 | 105 | 6 | 1535_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.67e-04 | 176 | 105 | 6 | 2639_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.73e-04 | 177 | 105 | 6 | 3177_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.78e-04 | 178 | 105 | 6 | 1471_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.84e-04 | 179 | 105 | 6 | 6609_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.89e-04 | 180 | 105 | 6 | 4821_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.95e-04 | 181 | 105 | 6 | 3643_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.95e-04 | 181 | 105 | 6 | 7077_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 2.01e-04 | 182 | 105 | 6 | 1951_DN | |
| Drug | scriptaid; Down 200; 10uM; PC3; HT_HG-U133A | 2.01e-04 | 182 | 105 | 6 | 6896_DN | |
| Drug | Rim-1 | 2.09e-04 | 5 | 105 | 2 | CID003081320 | |
| Drug | Perphenazine [58-39-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.13e-04 | 184 | 105 | 6 | 1540_UP | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 2.26e-04 | 186 | 105 | 6 | 2684_UP | |
| Drug | Isoconazole [27523-40-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.26e-04 | 186 | 105 | 6 | 2218_UP | |
| Drug | Dequalinium dichloride [522-51-0]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 2.32e-04 | 187 | 105 | 6 | 5396_UP | |
| Drug | H-7 dihydrochloride; Down 200; 100uM; MCF7; HT_HG-U133A | 2.46e-04 | 189 | 105 | 6 | 5936_DN | |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A | 2.53e-04 | 190 | 105 | 6 | 7070_UP | |
| Drug | Glucose | COL12A1 PHLDA1 MAML1 LAMB1 PRPF6 CPT1A CREBBP MEF2D DDIT3 JUN TLK1 PBRM1 RBM14 TRIM8 DYNC1LI1 SYP PRNP | 2.61e-04 | 1420 | 105 | 17 | ctd:D005947 |
| Drug | Etofenamate [30544-47-9]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 2.68e-04 | 192 | 105 | 6 | 4108_UP | |
| Drug | Monensin sodium salt [22373-78-0]; Up 200; 5.8uM; HL60; HT_HG-U133A | 2.68e-04 | 192 | 105 | 6 | 2580_UP | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; MCF7; HT_HG-U133A | 2.68e-04 | 192 | 105 | 6 | 3400_DN | |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 2.68e-04 | 192 | 105 | 6 | 7427_DN | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 2.68e-04 | 192 | 105 | 6 | 2123_UP | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 2.76e-04 | 193 | 105 | 6 | 4321_DN | |
| Drug | Bromperidol [10457-90-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.76e-04 | 193 | 105 | 6 | 2872_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.76e-04 | 193 | 105 | 6 | 1022_DN | |
| Drug | indomethacin, USP; Up 200; 20uM; MCF7; HG-U133A | 2.76e-04 | 193 | 105 | 6 | 262_UP | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.83e-04 | 194 | 105 | 6 | 3861_DN | |
| Drug | semustine; Up 200; 100uM; MCF7; HT_HG-U133A | 2.83e-04 | 194 | 105 | 6 | 7487_UP | |
| Drug | Phensuximide [86-34-0]; Down 200; 21.2uM; MCF7; HT_HG-U133A | 2.83e-04 | 194 | 105 | 6 | 3521_DN | |
| Drug | Citalopram hydrobromide [59729-32-7]; Down 200; 1uM; MCF7; HT_HG-U133A | 2.83e-04 | 194 | 105 | 6 | 3903_DN | |
| Drug | Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.83e-04 | 194 | 105 | 6 | 6835_UP | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 2.83e-04 | 194 | 105 | 6 | 4312_DN | |
| Drug | F0447-0125; Up 200; 10uM; MCF7; HT_HG-U133A | 2.83e-04 | 194 | 105 | 6 | 6424_UP | |
| Drug | clofibrate; Up 200; 150uM; MCF7; HG-U133A | 2.83e-04 | 194 | 105 | 6 | 263_UP | |
| Drug | Beta-Escin [11072-93-8]; Up 200; 3.2uM; MCF7; HT_HG-U133A | 2.91e-04 | 195 | 105 | 6 | 3890_UP | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 2.91e-04 | 195 | 105 | 6 | 2624_UP | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 2.91e-04 | 195 | 105 | 6 | 5455_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A | 2.91e-04 | 195 | 105 | 6 | 1639_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | 2.91e-04 | 195 | 105 | 6 | 2702_UP | |
| Drug | Sulfameter [651-06-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 2.99e-04 | 196 | 105 | 6 | 3453_DN | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; HL60; HT_HG-U133A | 2.99e-04 | 196 | 105 | 6 | 2198_DN | |
| Drug | Torsemide [56211-40-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 2.99e-04 | 196 | 105 | 6 | 3517_UP | |
| Drug | Trimethadione [127-48-0]; Down 200; 28uM; MCF7; HT_HG-U133A | 2.99e-04 | 196 | 105 | 6 | 4165_DN | |
| Drug | Iopamidol [60166-93-0]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 2.99e-04 | 196 | 105 | 6 | 3473_UP | |
| Drug | Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 2.99e-04 | 196 | 105 | 6 | 3971_UP | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.99e-04 | 196 | 105 | 6 | 2262_UP | |
| Disease | Schizophrenia | SHANK1 SETD1A DDR1 TCF4 TNFSF13 RANBP9 SLC6A4 JUN PBRM1 SYP CTNND2 CSMD1 EN1 | 1.26e-05 | 883 | 103 | 13 | C0036341 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.60e-05 | 152 | 103 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Ethylmalonic encephalopathy | 3.61e-05 | 3 | 103 | 2 | C1865349 | |
| Disease | Polydactyly | 5.78e-05 | 117 | 103 | 5 | C0152427 | |
| Disease | hair colour measurement | FOXE1 FRAS1 SHROOM3 ZBTB38 ADGRV1 ZMIZ1 ARID1A MSI2 NFIA PRNP | 5.97e-05 | 615 | 103 | 10 | EFO_0007822 |
| Disease | parental longevity | 5.99e-05 | 494 | 103 | 9 | EFO_0007796 | |
| Disease | Eosinophilic esophagitis | 7.21e-05 | 4 | 103 | 2 | C0341106 | |
| Disease | Malignant neoplasm of breast | EPOR FLNA ZMIZ1 CUBN CPT1A ARID1A WNK1 DDIT3 HOXA3 JUN PBRM1 SMARCD1 ZBTB3 | 9.45e-05 | 1074 | 103 | 13 | C0006142 |
| Disease | Nonorganic psychosis | 1.02e-04 | 69 | 103 | 4 | C0349204 | |
| Disease | Klatskin's tumor (is_implicated_in) | 1.20e-04 | 5 | 103 | 2 | DOID:4927 (is_implicated_in) | |
| Disease | anxiety disorder (is_implicated_in) | 1.79e-04 | 6 | 103 | 2 | DOID:2030 (is_implicated_in) | |
| Disease | colorectal cancer | 2.71e-04 | 604 | 103 | 9 | MONDO_0005575 | |
| Disease | uric acid measurement | 2.91e-04 | 610 | 103 | 9 | EFO_0004761 | |
| Disease | albuminuria | 3.36e-04 | 94 | 103 | 4 | EFO_0004285 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 4.00e-04 | 41 | 103 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 4.00e-04 | 41 | 103 | 3 | C0858252 | |
| Disease | Adenoid Cystic Carcinoma | 4.25e-04 | 100 | 103 | 4 | C0010606 | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 4.28e-04 | 9 | 103 | 2 | DOID:1925 (implicated_via_orthology) | |
| Disease | Psychotic Disorders | 4.41e-04 | 101 | 103 | 4 | C0033975 | |
| Disease | brain ischemia (biomarker_via_orthology) | 4.58e-04 | 102 | 103 | 4 | DOID:2316 (biomarker_via_orthology) | |
| Disease | Hypermetropia | 4.75e-04 | 103 | 103 | 4 | HP_0000540 | |
| Disease | glucagon-like peptide-1 measurement | 5.33e-04 | 10 | 103 | 2 | EFO_0008465 | |
| Disease | Breast Carcinoma | 6.06e-04 | 538 | 103 | 8 | C0678222 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.21e-04 | 195 | 103 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | cannabis dependence measurement | 6.37e-04 | 48 | 103 | 3 | EFO_0008457 | |
| Disease | QRS amplitude, QRS complex | 7.19e-04 | 50 | 103 | 3 | EFO_0005054, EFO_0007742 | |
| Disease | neuroblastoma | 7.43e-04 | 116 | 103 | 4 | EFO_0000621 | |
| Disease | disks large homolog 3 measurement | 7.78e-04 | 12 | 103 | 2 | EFO_0802472 | |
| Disease | hair color | 7.93e-04 | 311 | 103 | 6 | EFO_0003924 | |
| Disease | Colorectal Carcinoma | 7.98e-04 | 702 | 103 | 9 | C0009402 | |
| Disease | Peripheral Nervous System Diseases | 9.00e-04 | 54 | 103 | 3 | C4721453 | |
| Disease | total blood protein measurement | 1.02e-03 | 449 | 103 | 7 | EFO_0004536 | |
| Disease | ventricular septal defect (is_implicated_in) | 1.07e-03 | 14 | 103 | 2 | DOID:1657 (is_implicated_in) | |
| Disease | alcohol consumption measurement | SETD1A TCF4 ZBTB38 COL12A1 TNFSF13 ADGRV1 HIBADH SLC6A4 RASIP1 NFIA CTNND2 CSMD1 | 1.31e-03 | 1242 | 103 | 12 | EFO_0007878 |
| Disease | platelet component distribution width | 1.32e-03 | 755 | 103 | 9 | EFO_0007984 | |
| Disease | neutrophil percentage of leukocytes | 1.36e-03 | 610 | 103 | 8 | EFO_0007990 | |
| Disease | risk-taking behaviour | 1.44e-03 | 764 | 103 | 9 | EFO_0008579 | |
| Disease | Neoplastic Cell Transformation | 1.45e-03 | 139 | 103 | 4 | C0007621 | |
| Disease | opioid dependence | 1.48e-03 | 237 | 103 | 5 | EFO_0005611 | |
| Disease | Malignant neoplasm of liver | 1.57e-03 | 142 | 103 | 4 | C0345904 | |
| Disease | Liver neoplasms | 1.57e-03 | 142 | 103 | 4 | C0023903 | |
| Disease | major depressive disorder (is_implicated_in) | 1.59e-03 | 17 | 103 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | serum non-albumin protein measurement | 1.70e-03 | 361 | 103 | 6 | EFO_0004568 | |
| Disease | Feeding difficulties | 1.78e-03 | 18 | 103 | 2 | C0232466 | |
| Disease | borna disease (biomarker_via_orthology) | 1.78e-03 | 18 | 103 | 2 | DOID:5154 (biomarker_via_orthology) | |
| Disease | noggin measurement | 1.78e-03 | 18 | 103 | 2 | EFO_0021995 | |
| Disease | melanoma | 1.81e-03 | 248 | 103 | 5 | C0025202 | |
| Disease | JT interval | 1.81e-03 | 248 | 103 | 5 | EFO_0007885 | |
| Disease | resting heart rate | 1.87e-03 | 149 | 103 | 4 | EFO_0004351 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 1.92e-03 | 150 | 103 | 4 | EFO_0004611, EFO_0020947 | |
| Disease | prion disease | 1.99e-03 | 19 | 103 | 2 | EFO_0004720 | |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 1.99e-03 | 19 | 103 | 2 | EFO_0002609, GO_0031427 | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 1.99e-03 | 19 | 103 | 2 | DOID:4928 (is_marker_for) | |
| Disease | Liver carcinoma | 2.04e-03 | 507 | 103 | 7 | C2239176 | |
| Disease | anti-Mullerian hormone measurement | 2.20e-03 | 20 | 103 | 2 | EFO_0004769 | |
| Disease | response to ziprasidone | 2.20e-03 | 20 | 103 | 2 | GO_0097337 | |
| Disease | Amphetamine-Related Disorders | 2.32e-03 | 75 | 103 | 3 | C0236733 | |
| Disease | Amphetamine Abuse | 2.32e-03 | 75 | 103 | 3 | C0236807 | |
| Disease | Amphetamine Addiction | 2.32e-03 | 75 | 103 | 3 | C0236804 | |
| Disease | creatinine measurement | 2.53e-03 | 995 | 103 | 10 | EFO_0004518 | |
| Disease | memory performance | 3.16e-03 | 409 | 103 | 6 | EFO_0004874 | |
| Disease | Intrahepatic Cholangiocarcinoma | 3.17e-03 | 24 | 103 | 2 | C0345905 | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 3.17e-03 | 24 | 103 | 2 | DOID:3827 (biomarker_via_orthology) | |
| Disease | Extrahepatic Cholangiocarcinoma | 3.17e-03 | 24 | 103 | 2 | C3805278 | |
| Disease | pulse pressure measurement | TCF4 SHROOM3 LIN54 MSI2 HOXA3 HOXB7 PBRM1 MEGF8 LPP TRIM8 ELN CTNND2 | 3.37e-03 | 1392 | 103 | 12 | EFO_0005763 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GPNSYPGSTGAAVGA | 1746 | P55196 | |
| GTYNGTSSPEPGAVV | 71 | Q9Y2D5 | |
| TGSSGVILSPGYPGN | 2326 | Q96PZ7 | |
| APGDGQAAQGPTISY | 726 | Q08345 | |
| SPQNGATFPSSGGYG | 6231 | Q8WXG9 | |
| GLPSEGASEGNQYTP | 271 | Q8N4X5 | |
| GNTSPFGQPFSQAGG | 271 | Q92793 | |
| RGQTYGGGQGVSPDF | 386 | O94983 | |
| NNPEYVSSGGGFGPV | 701 | P50416 | |
| SGESYQAPDPGNGSI | 451 | Q8TAM1 | |
| QRGGSAPEGATYAAP | 281 | Q9UQB3 | |
| GAGVPAGPSQGQTNY | 656 | Q07912 | |
| GSGISSYGNNPQDVP | 96 | O75355 | |
| EPFYTGQGRSPGSGS | 291 | Q12857 | |
| GTGQPYGPTFTTGDV | 266 | Q96S59 | |
| GNSSGRGGSPAPYVD | 411 | Q5U651 | |
| GGAQPSASALSSYGG | 306 | Q96PK6 | |
| RGQPGNAYDGAGQPS | 541 | Q96PK6 | |
| SGQTYGPETDGQPGF | 236 | Q5T481 | |
| GNYISAASPQPGSGF | 296 | Q96DH6 | |
| SGDGYRGQTSPHTPN | 496 | Q32P28 | |
| EEYSNSGGGGSPSPS | 591 | Q96TA1 | |
| GGTNPYSQQQGPPSG | 396 | O14497 | |
| PPAESVGNGGSKYSQ | 576 | Q6GQQ9 | |
| AGQELPFAYSGQPGG | 966 | Q92585 | |
| PFAYSGQPGGSGLSS | 971 | Q92585 | |
| SATGGCPFGPYQGRQ | 486 | Q8IY17 | |
| RPGSGQSSGFGQYGS | 1106 | Q5D862 | |
| GIPEGPYSEGGNGSS | 136 | Q6Y2X3 | |
| APGGSPYGQQVGVLG | 1551 | Q86U86 | |
| QPEYSHGTGEPGGSF | 2156 | Q86XX4 | |
| GTVLAPAPGTGNVGY | 456 | Q6MZP7 | |
| GNGSYGTPHIQGSPV | 351 | O43365 | |
| FNPGALSSGGGAPSY | 176 | P05412 | |
| NGGHPSPSRNYGDGT | 61 | P15884 | |
| GGQASSSPNYEGPLH | 366 | P15884 | |
| PGAYPSSGQPSATGA | 86 | P17931 | |
| ASDGEGGTPQPSRAY | 1456 | Q9UPA5 | |
| GSGGGGPDLVQYQPQ | 2116 | Q9UPA5 | |
| PGNLAQYGPAAGQGT | 2161 | Q9UPA5 | |
| PQYSAGSGGPTQNGF | 3061 | Q9UPA5 | |
| YTGGPLGNEIASGNG | 21 | Q9Y6G9 | |
| DVPGGGISSYADNPS | 76 | Q9Y5L3 | |
| TFGLAGGGYENPVGQ | 676 | Q9H6A9 | |
| ADSAPYPGGGGNGAS | 201 | O60245 | |
| PGFVTDGAGNYSVNG | 41 | Q7Z7M0 | |
| SGAQSGTPPTGLYGH | 1661 | Q7Z7M0 | |
| AAPSSGQIYGSGPQG | 236 | Q93052 | |
| GYFGNPSEVGGSCQP | 961 | P07942 | |
| SPGDPQAEGSAAGYR | 431 | Q8NCW0 | |
| SGAGTSAGNGYGNPR | 206 | Q06413 | |
| SAGNGYGNPRNSPGL | 211 | Q06413 | |
| GAGSPGAQGTKYPEH | 231 | Q05925 | |
| GTGQGTPFSYSVPGQ | 331 | O95502 | |
| GGTPQGIGSPSVYHA | 26 | Q96MC6 | |
| GQGGSYGQGYPTPSS | 226 | P32242 | |
| PAAAYNLGGVAQPSG | 151 | Q99853 | |
| QGAAFSPEGQPIGGY | 316 | A8K0S8 | |
| SNPQRPGYGAGSGAS | 36 | P09629 | |
| TSYSPGGQGAGAQPE | 426 | Q7Z3G6 | |
| PASNQHGVYSAPGGG | 371 | P15863 | |
| NTPEGNFTSPGYDGV | 2576 | O60494 | |
| NGGSPESPIIGQYCG | 2751 | O60494 | |
| PQASADSPPYGSGGG | 226 | Q92908 | |
| ALYSDGEGNPSPAQG | 2006 | Q99715 | |
| YPGNSAGSFGMNPQG | 176 | Q6E0U4 | |
| QQGPVGVNVTYGGDP | 941 | P21333 | |
| LSTKPQDPYGGGGQS | 171 | Q6UUV7 | |
| GSQGSPGSRGAPGQY | 1491 | A8TX70 | |
| GDSQGAQGGLSDGPY | 471 | P19235 | |
| SDENGGTYVSPPGNE | 31 | P35638 | |
| ATEGGFGGPGSYTPQ | 791 | Q9C0E4 | |
| FGGPGSYTPQAAARG | 796 | Q9C0E4 | |
| KAGYPTGTGVGPQAA | 241 | P15502 | |
| EGGPTLPGVGPNYNS | 516 | Q9UJQ4 | |
| PNYNSPRAGGFQGSG | 526 | Q9UJQ4 | |
| GQGYSSGPGTSPEAQ | 336 | P28906 | |
| PGDGLSSPAGGSYET | 466 | Q14814 | |
| DEESQGPQSGGDSPY | 1196 | Q9P2P1 | |
| SDPGGPVNGYQKITG | 281 | Q6UXH9 | |
| LGTYPADPQAGGDNP | 706 | Q8ND04 | |
| GQQGYGPQGAPTSFS | 296 | P08247 | |
| YDVPNASGGQAGGPQ | 36 | Q13671 | |
| GLPTPRGSGTNGYVQ | 6 | Q9UQ35 | |
| YGGNPSVRPGLAQSG | 81 | Q96GM5 | |
| PSSYHPGDGAQLNGG | 81 | Q8N5C8 | |
| LSQNGSFGPSPVSGG | 1661 | Q5JRA6 | |
| SAGAPATTTGYQPAG | 251 | O00358 | |
| QFGGLNTPYPGGLNT | 206 | O94906 | |
| NPVGTGFSYVNGSGA | 116 | Q9HB40 | |
| YGGSQGSGQTLNRPP | 76 | O95486 | |
| PGPGSASALQGFQYG | 761 | Q8TF72 | |
| YGNTPLSEAAAGGQP | 191 | A8MXQ7 | |
| AYPAGTTAVGTPGNG | 226 | O15047 | |
| YLDGQAFGGSSTPGP | 1731 | Q9Y566 | |
| GVPSANNYQGGFGTT | 266 | P31937 | |
| DQGSTYSPARGVAGP | 526 | Q96S66 | |
| SAFGAAGYGGAQPTP | 141 | Q9Y446 | |
| SEYTPGNPEAAGNSG | 121 | Q96CW6 | |
| EYQGGNGSSPVRGIP | 151 | Q9UKI8 | |
| LPVDTGAGGYSGNSG | 701 | Q92738 | |
| SYGQEPTLGPTDSNG | 581 | P60852 | |
| VGSTGTAPPGDGYVQ | 386 | P98077 | |
| GNGEAEPSGGPSYAG | 126 | Q8WV24 | |
| GPGAPQYPAGTQGEQ | 146 | Q99619 | |
| WNTGGSRYPGQGSPG | 31 | P04156 | |
| GYSPQLQGLSSGGSG | 161 | Q96SK2 | |
| AGGEPQSGSSQGLYG | 746 | Q9ULT6 | |
| PSYGHQPQTGSGESS | 36 | O43294 | |
| NYPTIGQNGGSFTGP | 411 | Q8NAP3 | |
| GVYPPSSVAQGQSQG | 706 | Q9H4A3 | |
| GLSGGSGFPYGVTNN | 106 | O75604 | |
| GQISNGYSAVPSPGA | 41 | P31645 | |
| TSSGPVGGQYGAAGT | 391 | Q9BZR9 | |
| QGTGGPSQNGEGYPW | 66 | O75888 | |
| SGEPGQPEGKGQETY | 91 | Q6F5E7 | |
| PPPGGTNSNDYSSQG | 876 | Q9ULJ6 | |
| EGAFPNGTDQGIYPG | 236 | Q8TF47 | |
| PSGGAVYGAQPSQPE | 381 | Q9H5J0 |